MOORE WILLIAM M

Director William M Moore buys 2,000 shares of IRIX at $1.01 on 2025-12-16, adding to recent purchases.

Director Moore purchased 2,000 shares at $1.01 on 2025-12-16, extending a pattern of recent buys at this ticker—he acquired shares on 2025-12-15, 2025-12-12, and 2025-12-11 as well. His post-transaction holdings of 251,550 shares represent a 0.8% increase. The current stock price of $0.97 sits -47.0% from the 52-week high of $1.83, and the company remains unprofitable with net income of $-1,573,000.00 over its most recent full fiscal year. While Moore's cross-ticker track record shows a 90.00% 90-day win rate across 15 prior buys, his same-ticker history at IRIX shows mixed near-term results: his 2025-11-17 purchase returned +2.6% over 30 days, but his 2025-11-14 purchase returned -4.8% over the same interval. The timing pattern at IRIX shows 0 of 0 prior buys were well-timed at the 90-day mark.

Director William M Moore bought 20,000 shares of IRIX, boosting holdings 8.7% to 249,550 shares; stock down 45.4% from 52-week high.

William M Moore, a director of IRIDEX, purchased 20,000 shares on 2025-12-15, expanding his stake by 8.7% from 229,550 to 249,550 shares. The stock currently trades at $1.00, positioned -45.4% below its 52-week high of $1.83 and showing a 90-day decline of 22.5%. IRIDEX is unprofitable with net income of $-1.6M on $12.5M quarterly revenue and declining annual growth of -6.2%, leaving the company in a challenging financial position. Moore's cross-ticker track record shows a 90% win rate on prior buys over 90 days, though his same-ticker history at IRIX lacks measurable outcomes beyond the 30-day mark for all five recent purchases (clustered from 2025-11-14 through 2025-12-16), providing limited visibility into execution quality at this specific company.

Director Moore bought 30,000 shares (30.0K) at $0.00 across 2 transactions on 2025-12-11/12 at IRIX

Director William M Moore acquired 30,000 shares (30.0K shares) at $0.00 per share in 2 separate transactions on 2025-12-11 and 2025-12-12, increasing his holdings from 250.7K shares to 280.7K shares (+12.0% vs pre-transaction holdings). The zero-dollar transaction price indicates these were non-open-market acquisitions (likely restricted stock awards, vesting, or similar equity compensation) rather than discretionary open-market purchases driven by market conviction. IRIX trades at $0.99, down -45.9% from its 52-week high of $1.83, and the company remains unprofitable (net income $-1.6M in the latest quarter, annual revenue growth -6.2% year-over-year). Among Moore's 5 prior trades at IRIX, only 1 of 2 measurable buys on a 90-day basis proved well-timed, and his cross-ticker track record shows 90.00% win rate over 90 days but an average 30-day return of -4.7%.

Director Moore buys 50,000 shares at $0.97 across 2 transactions; stock now $0.93, down 27.3% in 90 days from $12.5M quarterly revenue, -$1.6M net income.

William M. Moore, a Director, purchased 50,000 shares (50.0K shares) in two separate open-market transactions on 2025-11-14 and 2025-11-17 at a blended average of $0.97 per share, investing $48,331.94. This represents a 24.9% increase to his holdings, raising them from 200,674 shares to 250,674 shares. The timing is notable: IRIX is trading at $0.93, down 27.3% over 90 days and 51.0% below its 52-week high of $1.90, while the company reported quarterly revenue of $12,484,000 and net income of $-1,573,000, with annual revenue declining 6.2% year-over-year. Moore's prior buy activity at IRIX shows a 4-of-5 success rate at the 90-day mark, suggesting his historical timing at this ticker has favored later stock recovery; however, his cross-ticker track record shows a 90-day win rate of 90.00% with an average 90-day return of +21.4%, providing context for his general stock-picking accuracy. The current purchase occurs amid financial pressure and significant price weakness, yet the insider is adding to a position he has repeatedly accumulated over recent months.

IRIX Director Moore buys 12,024 shares at $1.18; stock down 42.9% from 52-week high, company unprofitable.

William M Moore, a director at IRIDEX Corp, purchased 12,024 shares at $1.18 on 2025-08-18, bringing his holdings to 200,674 shares. The acquisition occurs at a depressed absolute price point: the stock trades at $1.16 (current price), down 42.9% from its 52-week high of $2.03 and down 7.9% over the past 30 days. At the same-ticker level, Moore's prior 2 measurable buys at IRIX (May 2025) both produced positive 90-day returns (+17.9% and +18.1%), establishing a pattern of well-timed entry points at this stock. However, the company's fundamentals remain stressed: the latest quarter showed net income of $-994,000.00, annual revenue declined 6.2% year-over-year, and the company was unprofitable over its most recent full fiscal year. The purchase extends Moore's buying activity at IRIX despite these headwinds, though at a notably lower absolute price than the stock's recent trading range.

Director Moore buys 20,000 IRIX shares at $0.97; stock -55.7% from 52-week high, company unprofitable with -6.2% revenue decline

Director William M Moore purchased 20,000 shares at $0.97 on 2025-06-13, increasing his holdings to 188,650 shares, as IRIDEX trades $0.98 versus a 52-week high of $2.21 (down -55.7%). The company reported net income of $-1.7M on quarterly revenue of $11.9M and annual revenue decline of -6.2%, operating unprofitably over the most recent full fiscal year. Moore's prior trades at IRIX show negative 30-day returns: -6.1% (2025-05-15), -14.6% (2025-05-14), and -13.0% (2025-04-29), with none yet measurable at the 90-day mark. His cross-ticker track record across 8 prior buys shows an average 30-day return of -11.5%, indicating historically poor near-term entry timing. A cluster pattern shows 2 other insiders also bought within the past 14 days, though this does not establish coordinated confidence given the negative outcomes of recent buys at this ticker and the company's deteriorating fundamentals.

Director Moore buys 30,000 shares ($0.96–$0.97) as stock trades down 57.5% from 52-week high; unprofitable company shows clustering.

WILLIAM M MOORE, a director at IRIDEX CORP, purchased 30,000 shares across 2 separate transactions on 2025-06-11 and 2025-06-12 at prices of $0.96 and $0.97, respectively, totaling $29,121.00. This represents a 21.6% increase in his holdings to 168,650 shares. However, the context is concerning: the stock has declined 57.5% from its 52-week high of $2.21 and is down 6.0% over the past 30 days, while IRIDEX reported a latest-quarter revenue of $11,896,000.00 and net income of -$1,686,000.00, with annual revenue declining 6.2% year-over-year. Moore's prior trades at IRIX show a pattern of purchases followed by declines: his most recent prior buys registered 30-day returns of -14.6%, -13.0%, and -23.6%, with none of his 5 prior IRIX trades achieving a positive 90-day return. This purchase coincides with a cluster pattern—2 other insiders also bought within the past 14 days—which may indicate some coordinated response to depressed valuations, but the company's financial deterioration and the insider's poor historical timing on this specific ticker suggest caution rather than confidence.

Director Moore buys 17,500 shares in 2 tranches ($19.0K) as IRIX stock sits -67.5% from 52-week high and company posts -$1.7M net loss.

William M Moore, Director of IRIDEX, executed 2 separate purchases totaling 17,500 shares for $19,008.50 at a blended average price of $1.09 on May 14–15, 2025. The purchases expand his holding by 14.4% to 138,650 shares at a time when the stock is trading 67.5% below its 52-week high and down 34.8% over the past 90 days. The company is unprofitable (net income of -$1.7M in the latest quarter) with declining annual revenue (-6.2% year-over-year) and a market cap of $17.0M. Moore has a pattern of 4 prior purchases at IRIX within the preceding three weeks (April 21–29), all too recent to yet show measurable 30 or 90-day outcomes. The cumulative buying activity — multiple tranches within a compressed timeframe against a deteriorating backdrop — warrants tracking to assess whether the director sees value that markets have not yet repriced.

Director Moore purchases 20,000 shares at $1.21–$1.24; cluster buy pattern with 4 other insiders in 14 days.

Director William M Moore executed 2 separate purchases totaling 20,000 shares (20.0K shares) for $24,143.66, raising his holdings from 101,150 to 121,150 shares. The transactions occurred at $1.24 and $1.21, near the current price of $1.19. The company is unprofitable with quarterly revenue of $11,581,000.00 and net income of $-1,933,000.00; annual revenue has contracted 6.2%. A cluster pattern is present: 4 other insiders also bought within the past 14 days. Moore's cross-ticker track record shows only 2 prior open-market buys, limiting historical context for evaluating his purchase timing at this company.

Director William M Moore purchased 20,000 shares at blended average $1.07 amid cluster buy pattern; stock currently $1.22, down -60.8% from 52-week high

Director William M Moore purchased 2 separate tranches totaling 20,000 shares for $21,371.00 ($21.4K) at an average price of $1.07, increasing his holdings by 24.6% to 101.2K shares. The purchases occurred as the stock trades at $1.22, substantially below its 52-week high of $3.11 (-60.8%), and the transaction is part of a cluster pattern with 2 other insiders buying within the past 14 days. The company's current fundamentals show net losses of $-1.9M in the latest quarter and negative full-year net income, while revenue declined 6.2% year-over-year, indicating operational headwinds that investors should track against any insider accumulation signals.